601 Children's Lane, Norfolk, VA, 23507 · (757) 668-9647
Beds
192
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$733.4M
FY 2025
Net income
$128.1M
Patient care margin 3.9%
Discharges
4,556
Occupancy 64.4%
Clinicians
21
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $733.4M | $705.1M | 3.9% | $128.1M | 4,556 | - | 0.1% | 63.5% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 8011 Comprehensive Observation Services | - | - | - | $2,090.36 |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $588.8M | $646.5M | -9.8% | $39.9M | 4,865 | - | 0.1% | 64.7% |
| 2023 | $546.2M | $600.1M | -9.9% | $50.9M | 5,357 | - | 0.2% | 64.2% |
| 2022 | $516.3M | $518.7M | -0.5% | $50.9M | 4,834 | - | 0.2% | 63.3% |
| 2021 | $381.0M | $447.8M | -17.6% | $59.2M | 4,366 | - | 0.4% | 67.5% |
| 2020 | $424.2M | $430.7M | -1.5% | $47.9M | 5,112 | - | 0.2% | 66.1% |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 20 | $41K |
| Pfizer Inc. PFE | 3 | $13K |
| Tandem Diabetes Care, Inc. TNDM | 19 | $13K |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $5,576 |
| Biogen, Inc. BIIB | 2 | $4,134 |
| Medtronic, Inc. MDT | 7 | $2,175 |
| Incyte Corporation INCY | 1 | $1,000 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $228 |
| Neurelis, Inc. | 1 | $106 |
| Medline Industries LP | 1 | $74.67 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Childrens Hospital of the Kings Daughters Inc is a nonprofit children's hospital in Norfolk, VA with 192 beds, part of Childrens Hospital of the Kings Daughters Health System.
Childrens Hospital of the Kings Daughters Inc in Norfolk, VA has 192 beds (fiscal year 2025 cost report); 206 beds are certified for Medicare. It discharged 4,556 inpatients that year, with 64.4% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Childrens Hospital of the Kings Daughters Inc reported net patient revenue of $733.4M and operating expenses of $705.1M, a margin on patient care of 3.9%. After other income and expenses its net income was $128.1M (15.3% of revenue), so it made a profit that year.
Childrens Hospital of the Kings Daughters Inc is part of Childrens Hospital of the Kings Daughters Health System, a health system with 1 hospitals based in Norfolk, VA. It is a nonprofit hospital.
Childrens Hospital of the Kings Daughters Inc has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Childrens Hospital of the Kings Daughters Inc provides emergency services.
21 Medicare clinicians list Childrens Hospital of the Kings Daughters Inc as a hospital they work at, most often in Pediatric Medicine, Physical Medicine and Rehabilitation, Pulmonary Disease.
In 2025, companies reported $80K in payments to Childrens Hospital of the Kings Daughters Inc as a teaching hospital ($56K general and $24K for research) from 11 companies.